Indiana University 27th Annual IU Gastroenterology & Hepatology Update 2025

Description Include: 30 Videos (.mp4) No PDFS Information: 1. Overview Friday, April 4 – Saturday, April 5,2025, Marriott Indianapolis North The Indiana University 27th Annual IU Gastroenterology & Hepatology Update 2025 offers a comprehensive review of the latest advancements in digestive and liver disease management. This course bridges the gap between adult and pediatric gastroenterology, covering essential topics such as motility disorders, liver transplantation, advanced endoscopic techniques, and metabolic health. 2. Learning Objectives Evaluate and treat common pediatric and adult GI conditions, including celiac disease, chronic diarrhea, and constipation. Apply updated clinical management strategies for Eosinophilic Esophagitis (EoE), GERD, and Clostridioides difficile infections. Discuss the latest screening and surveillance protocols for esophageal, liver, and pancreatic cancers. Analyze complex liver conditions, including MASLD, alcohol-related liver disease, and drug-induced liver injury (DILI). Review advanced endoscopic interventions for biliary obstruction, large stones, and weight loss management. 3. Target Audience Sr No Topic Time 1 Updates in Celiac Disease 2025 18:13 2 Finding Some Consistency: Pediatric Diarrhea and Constipation for the Physician in Primary Care 22:35 3 Clostridioides difficile (C. diff) 23:42 4 Approach to Diarrhea in Adults 06:33 5 IBD Panel Discussion – Adults, Peds, Transition 11:44 6 Updates on Clinical Management of Eosinophilic Esophagitis (2025) 17:47 7 Gastroesophageal Reflux Disease (GERD) in Children 15:34 8 GERD – When to Start (PPIs), When to Stop (PPIs) and When to Wrap? 18:14 9 Live EMR of Previously Partially Resected Lesion 08:00 10 Live Endoscopic Challenge of Malignant Hilar Biliary Obstruction 27:14 11 Live Endoscopic Submucosal Dissection for Esophageal Squamous Cell Cancer 27:09 12 Post-Op Whipple: Live Endoscopic Therapy of Large Common Bile Duct Stones 26:49 13 Approach to Elevated Liver Tests 10:27 14 Drug Induced Liver Disease (DILI): It Is Rare but Not Uncommon 22:36 15 Updates in Rare Liver Diseases 17:37 16 Liver Panel Discussion 08:18 17 Esophageal Cancer Screening and Barrett’s Esophagus 15:05 18 Liver Based Cancer Screening 13:28 19 Pancreatic Cancer Screening 2025 12:06 20 Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Update 18:55 21 Weight Loss Medications and Endoscopic Weight Loss 14:56 22 Childhood Obesity Management 08:16 23 Bariatric Surgery 2025 16:25 24 Metabolic Disorders Panel Discussion 13:23 25 Alcohol-Related Disorders of the Liver 17:52 26 Liver Disease in the Pediatric World 25:13 27 Liver Transplantation Panel 20:48 28 Case Panel: Management of Chronic Pancreatitis 27:28 29 Cholecystitis Management for the Poor Surgical Candidate 15:38 30 Panel: Management of a Patient with Pancreatic Cysts 32:36